0JAX Stock Chart & Stats
$84.13
$3.08(3.66%)
At close: 4:00 PM EDT
$84.13
$3.08(3.66%)
Day’s Range― - ―
52-Week Range$66.00 - $96.61
Previous CloseN/A
Volume8.00
Average Volume (3M)102.00
Market Cap
$2.31B
Enterprise Value$1.82K
Total Cash (Recent Filing)$250.20M
Total Debt (Recent Filing)$47.90M
Price to Earnings (P/E)19.0
Beta0.71
Next Earnings
Nov 10, 2026EPS Estimate
1.27Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)4.91
Shares Outstanding24,631,046
10 Day Avg. Volume87
30 Day Avg. Volume102
Financial Highlights & Ratios
PEG Ratio0.07
Price to Book (P/B)1.44
Price to Sales (P/S)1.07
P/FCF Ratio21.64
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$110.00Price Target Upside30.75% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)4.81
Revenue Forecast (FY)$1.87B
Bulls Say, Bears Say
Bulls Say
Strong Balance Sheet & LiquidityInnospec’s net-cash position and negligible leverage provide durable financial flexibility. With ~$250M cash and no debt management can fund plant upgrades, maintain dividends and buybacks, and pursue targeted investments or M&A without stressing liquidity over the next 6–12 months.
Operational Recovery & Capacity UpsideOngoing plant repairs and optimizations targeted for completion by end‑Q4 should sustainably raise throughput and utilization. A structural >10% capacity uplift materially increases revenue potential and operating leverage, improving medium‑term margin durability once projects are online.
Diversified Segments With Resilient MarginsInnospec’s three distinct segments provide diversified end‑market exposure while preserving solid gross margins. That margin base cushions earnings against cyclical swings in any one end market and supports consistent cash generation and reinvestment capacity over a multi‑quarter horizon.
Bears Say
Top‑line Volatility And WeaknessPersistent revenue weakness and volatility limit sustainable operating leverage and make profitable growth harder to achieve. If end‑market demand or pricing fails to firm, margin recovery and resulting cash flow improvements will be constrained, raising execution risk over coming quarters.
Capex Outpacing Short‑term Cash GenerationQuarterly capex outstripping operating cash flow signals near‑term cash‑conversion pressure. With FCF momentum weakening recently, sustained high capex needs for repairs/expansions could strain free cash flow and limit flexibility for dividends, buybacks, or opportunistic investments.
Supply Disruptions And Margin PressureOperational outages reduced volumes and deferred sales, shifting expected recovery into late Q4/Q1. Reliance on timely completion of repairs creates execution risk and prolongs margin pressure, while lagging pricing versus raw‑material inflation can compress segment margins until operations normalize.
Innospec News
0JAX FAQ
What was Innospec Inc’s price range in the past 12 months?
Innospec Inc lowest share price was $66.00 and its highest was $96.61 in the past 12 months.
What is Innospec Inc’s market cap?
Innospec Inc’s market cap is $2.31B.
When is Innospec Inc’s upcoming earnings report date?
Innospec Inc’s upcoming earnings report date is Nov 10, 2026 which is in 89 days.
How were Innospec Inc’s earnings last quarter?
Innospec Inc released its earnings results on Aug 04, 2026. The company reported $1.27 earnings per share for the quarter, beating the consensus estimate of $1.047 by $0.223.
Is Innospec Inc overvalued?
According to Wall Street analysts Innospec Inc’s price is currently Undervalued.
Does Innospec Inc pay dividends?
Innospec Inc does not currently pay dividends.
What is Innospec Inc’s EPS estimate?
Innospec Inc’s EPS estimate is 1.27.
How many shares outstanding does Innospec Inc have?
Innospec Inc has 24,631,046 shares outstanding.
What happened to Innospec Inc’s price movement after its last earnings report?
Innospec Inc reported an EPS of $1.27 in its last earnings report, beating expectations of $1.047. Following the earnings report the stock price went up 7.085%.
Which hedge fund is a major shareholder of Innospec Inc?
Currently, no hedge funds are holding shares in GB:0JAX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Innospec Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$110.00 (30.75% Upside)
$110.00 (30.75% Upside)
Blogger Sentiment
Bullish
GB:0JAX Sentiment 100%
Sector Average 65%
Sector Average 65%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-27.02%
12-Months-Change
Fundamentals
Return on Equity
1.91%
Trailing 12-Months
Asset Growth
2.22%
Trailing 12-Months
Company Description
Innospec Inc
Innospec Inc., founded in 1938 as Octel Corp. and rebranded in January 2006, is a global company headquartered in Englewood, Colorado. It focuses on the creation, production, formulation, promotion, and distribution of unique chemical products. The company's operations span across the United States, the wider North American continent, the United Kingdom, continental Europe, and various international markets. Innospec's business is organized into distinct divisions. The Fuel Specialties segment provides a portfolio of specialized chemical additives engineered for various fuel applications. These crucial products are deployed in the functioning of engines for automobiles, maritime vessels, and aviation, as well as for electricity generators and heating oil systems. The Performance Chemicals division delivers sophisticated, technology-driven solutions designed to enhance customer processes or products. This unit primarily caters to sectors such as personal care, household products, agricultural chemicals, and metal recovery. Its Oilfield Services segment concentrates on developing and commercializing chemical solutions essential for fracturing, stimulating, and completing wells. This segment also supplies products that facilitate oil and gas extraction and prevent the loss of drilling mud during operations. Innospec sells its diverse range of products to a broad client base, including companies involved in oil and gas exploration and production, oil refining facilities, fuel producers and end-users, businesses in the personal care and home care industries, formulators of agrochemical and metal extraction products, and various other chemical and industrial enterprises.
0JAX Company Deck
0JAX Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a predominantly positive operational and financial picture: double-digit revenue growth, strong segment operating income gains (notably oilfield services and performance chemicals), no debt and $250M+ cash, and continued shareholder returns. Key challenges remain from earlier supply disruptions that constrained volumes, some margin compression (particularly in Fuel Specialties) and near-term cash conversion where capex exceeded operating cash in the quarter. Management provided clear remediation plans (plant repairs ~60% complete, expected full optimization by end-Q4 and >10% capacity upside), and guided to further operating income improvement in the second half, suggesting these challenges are being managed and that momentum should improve.View all GB:0JAX earnings summaries0JAX Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$110.00
▲(30.75% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month









